Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and

  Stock Price Movements of Healthcare Companies- Research Report on LabCorp,
    Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences

PR Newswire

NEW YORK, December 23, 2013

NEW YORK, December 23, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Laboratory
Corp. of America Holdings (NYSE: LH), Isis Pharmaceuticals, Inc. (NASDAQ:
ISIS), Mindray Medical International Limited (NYSE: MR), Clovis Oncology, Inc.
(NASDAQ: CLVS), and Sangamo Biosciences Inc. (NASDAQ: SGMO). Today's readers
may access these reports free of charge - including full price targets,
industry analysis and analyst ratings - via the links below.

Laboratory Corp. of America Holdings Research Report

On December 18, 2013, Laboratory Corp. of America Holdings' (LabCorp) stock
went up by 0.63%, closing the day at $90.11. Over the previous three trading
sessions, the Company's stock went up by 1.10%, compared to the S&P 500, which
went up by 1.99% during the same trading period. The Full Research Report on
Laboratory Corp. of America Holdings - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at:

http://www.analystscorner.com/r/full_research_report/c267_LH

Isis Pharmaceuticals, Inc. Research Report

On December 18, 2013, Isis Pharmaceuticals, Inc.'s (Isis Pharmaceuticals)
stock went up by 3.58%, to close at $39.07. Shares of Isis Pharmaceuticals
gained 5.20% during the past three trading days, compared to the Dow Jones
Industrial Average, which went up by 2.62% over the same period. The Full
Research Report on Isis Pharmaceuticals, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.analystscorner.com/r/full_research_report/fcfc_ISIS

Mindray Medical International Limited Research Report

On December 18, 2013, Mindray Medical International Limited's (Mindray) stock
declined 0.21%, ending the day at $37.85. For the past three trading days,
shares of Mindray went up by 2.02%, compared to the S&P 500, which advanced
1.99% during the same trading period. The Full Research Report on Mindray
Medical International Limited - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/8d4d_MR

Clovis Oncology, Inc. Research Report

On December 18, 2013, Clovis Oncology, Inc.'s (Clovis Oncology) stock
increased by 0.88%, ending the day at $55.16. For the past three trading days,
the Company's stock went up by 4.73%, compared to the Nasdaq Composite, which
gained 1.73% during the same trading period. The Full Research Report on
Clovis Oncology, Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/6a2a_CLVS

Sangamo Biosciences Inc. Research Report

On December 18, 2013, Sangamo Biosciences Inc.'s (Sangamo Biosciences) stock
climbed 1.94%, closing the day at $12.61. For the past three trading days,
Sangamo Biosciences stock went up by 3.45%, compared to the Dow Jones
Industrial Average, which went up by 2.62% during the same trading period. The
Full Research Report on Sangamo Biosciences Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.analystscorner.com/r/full_research_report/52a6_SGMO

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://www.AnalystsCorner.com

SOURCE Analysts' Corner

Contact: Contact: Joe Thomas, +1-310-496-8071 (North America)
 
Press spacebar to pause and continue. Press esc to stop.